Fig. 3From: Vasodilator-stimulated phosphoprotein-guided Clopidogrel maintenance therapy reduces cardiovascular events in atrial fibrillation patients requiring anticoagulation therapy and scheduled for percutaneous coronary intervention: a prospective cohort studyPatient distribution according to the clopidogrel maintenance dose modification profile in the VASP-guided group. VASP: vasodilator-stimulated phosphoproteinBack to article page